[D-Ser2] Leu-Enkephalin-Thr

[D-Ser2] Leu-Enkephalin-Thr, a synthetic opioid peptide analog, represents a valuable tool in the study of neurobiology and peptide-receptor interactions. As an engineered derivative of the naturally occurring enkephalin family, it incorporates a D-serine residue at the second position and an additional threonine at the C-terminus. This structural modification confers increased metabolic stability and selective receptor affinity, rendering the compound particularly useful for probing the functional dynamics of opioid systems. Researchers benefit from its enhanced resistance to enzymatic degradation, which allows for more reliable and reproducible experimental outcomes. The unique configuration of [D-Ser2] Leu-Enkephalin-Thr not only broadens its application potential but also facilitates detailed investigation into the mechanisms of peptide-receptor binding and downstream signaling pathways.

Opioid Receptor Research: [D-Ser2] Leu-Enkephalin-Thr is extensively utilized in the exploration of opioid receptor subtypes, particularly delta (δ) and mu (μ) receptors. Its modified sequence enables selective binding and activation, allowing scientists to dissect the nuanced roles these receptors play in neural signaling. By employing this peptide in binding assays, receptor mapping, and functional studies, researchers can elucidate receptor-ligand specificity, signaling cascades, and the molecular determinants of receptor selectivity. Such insights are instrumental in advancing our understanding of endogenous opioid system regulation and its implications for neuropharmacology.

Peptide Structure-Activity Relationship (SAR) Studies: The unique amino acid substitutions present in [D-Ser2] Leu-Enkephalin-Thr make it an exemplary candidate for SAR investigations. By comparing its biological activity and receptor affinity to other enkephalin analogs, researchers can determine the influence of specific residues on peptide function. These studies contribute to the rational design of novel peptide analogs with tailored pharmacological profiles, enhancing the development of research tools and potential therapeutic leads. The compound's stability and defined structure further facilitate high-resolution structural analyses, such as NMR and crystallography, deepening our understanding of peptide conformational dynamics.

Neurochemical Pathway Elucidation: As a stable and selective ligand, [D-Ser2] Leu-Enkephalin-Thr serves as a key probe in mapping neurochemical circuits mediated by opioid peptides. Its application in in vitro and ex vivo models enables the dissection of signal transduction mechanisms, neurotransmitter release modulation, and synaptic plasticity within the central nervous system. Through such studies, the compound aids in delineating the physiological roles of endogenous enkephalins and their contribution to neurobiological processes such as pain modulation, reward, and stress response.

Enzyme Inhibition and Peptide Degradation Studies: The resistance of [D-Ser2] Leu-Enkephalin-Thr to peptidase-mediated degradation makes it an ideal substrate for investigating the activity of neuropeptidases and other proteolytic enzymes. Researchers can utilize it to assess enzyme kinetics, substrate specificity, and the effects of enzyme inhibitors in controlled experimental settings. These studies provide valuable information on the regulation of peptide signaling in neural tissues and facilitate the identification of potential modulators of peptide stability.

Pharmacological Screening and Drug Discovery: The robust pharmacological profile of [D-Ser2] Leu-Enkephalin-Thr renders it a preferred standard in high-throughput screening and drug discovery platforms. Its predictable receptor interactions and metabolic resilience enable the evaluation of novel compounds targeting opioid pathways. By serving as a benchmark for efficacy and selectivity, the peptide supports the identification and optimization of new molecular entities with research and therapeutic potential. In summary, [D-Ser2] Leu-Enkephalin-Thr stands as a versatile and indispensable reagent in modern neuropeptide research, advancing scientific inquiry into opioid receptor biology, peptide structure-function relationships, neurochemical signaling, enzymatic regulation, and pharmacological innovation.

1. Multifunctional peptide-oligonucleotide conjugate promoted sensitive electrochemical biosensing of cardiac troponin I

2. Implications of ligand-receptor binding kinetics on GLP-1R signalling

3. The spatiotemporal control of signalling and trafficking of the GLP-1R

4. Zeta-potential-changing nanoparticles conjugated with cell-penetrating peptides for enhanced transfection efficiency

5. Emu oil in combination with other active ingredients for treating skin imperfections